HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Kato Selected Research

Bevacizumab (Avastin)

4/2022A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202).
12/2021Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II study.
12/2021[A Long-Survival Case of Lower Rectal Cancer with Unresectable Liver Metastases Treated with FOLFOXIRI plus Bevacizumab(BEV)].
12/2020Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
8/2020Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).
7/2020Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
7/2020Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).
1/2020Neutropenia is an indicator of outcomes in metastatic colorectal cancer patients treated with FTD/TPI plus bevacizumab: a retrospective study.
12/2019[A Case of Two Curative Resections for the Peritoneal Dissemination of Transverse Colon Cancer].
1/2018Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeshi Kato Research Topics

Disease

69Neoplasms (Cancer)
11/2022 - 08/2002
66Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 11/2002
36Neoplasm Metastasis (Metastasis)
03/2022 - 11/2002
29Stomach Neoplasms (Stomach Cancer)
01/2022 - 08/2002
18Atrial Fibrillation
02/2022 - 05/2007
15Colonic Neoplasms (Colon Cancer)
10/2022 - 01/2013
13Rectal Neoplasms (Rectal Cancer)
11/2022 - 10/2003
13Lymphatic Metastasis
04/2022 - 02/2008
10Neutropenia
12/2021 - 09/2014
10Hemorrhage
11/2021 - 11/2002
9Body Weight (Weight, Body)
01/2022 - 06/2014
9Breast Neoplasms (Breast Cancer)
02/2019 - 11/2012
7Carcinoma (Carcinomatosis)
02/2021 - 11/2009
7Diarrhea
07/2020 - 03/2005
7Pancreatic Neoplasms (Pancreatic Cancer)
02/2019 - 11/2013
7Adenocarcinoma
01/2018 - 11/2013
7Hepatocellular Carcinoma (Hepatoma)
11/2017 - 10/2003
6Inflammation (Inflammations)
11/2020 - 01/2008
6Hypersensitivity (Allergy)
01/2019 - 01/2002
5Insulin Resistance
11/2021 - 12/2010
5Heart Failure
11/2021 - 04/2015
5Esophageal Neoplasms (Esophageal Cancer)
04/2021 - 12/2008
4Peripheral Nervous System Diseases (PNS Diseases)
04/2021 - 08/2015
4Sigmoid Neoplasms
12/2019 - 11/2015
4Abscess
11/2017 - 08/2015
4Anorexia
10/2017 - 03/2007
4Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
05/2017 - 01/2014
4Nausea
01/2017 - 03/2007
4Fibrosis (Cirrhosis)
11/2014 - 04/2008
4Schizophrenia (Dementia Praecox)
02/2007 - 08/2004
3Pain (Aches)
03/2022 - 11/2009
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2022 - 02/2004
3Thrombosis (Thrombus)
01/2022 - 11/2012
3Hypertension (High Blood Pressure)
01/2022 - 11/2002
3Obesity
09/2021 - 12/2014
3Pathologic Constriction (Stenosis)
04/2021 - 11/2014
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2020 - 09/2009
3Cardiac Arrhythmias (Arrythmia)
11/2020 - 11/2011
3Disease Progression
01/2020 - 08/2012
3Malnutrition (Nutritional Deficiencies)
12/2018 - 06/2014

Drug/Important Bio-Agent (IBA)

28Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2022 - 12/2011
19Capecitabine (Xeloda)FDA Link
10/2022 - 02/2008
19Irinotecan (Camptosar)FDA LinkGeneric
12/2021 - 03/2005
17Fluorouracil (Carac)FDA LinkGeneric
10/2022 - 03/2007
17Bevacizumab (Avastin)FDA Link
04/2022 - 05/2014
16Leucovorin (Folinic Acid)FDA Link
10/2022 - 03/2007
12Pharmaceutical PreparationsIBA
01/2018 - 08/2002
10Messenger RNA (mRNA)IBA
01/2021 - 02/2013
9Circulating Tumor DNAIBA
04/2022 - 01/2017
9Cisplatin (Platino)FDA LinkGeneric
12/2018 - 11/2007
8CytokinesIBA
11/2020 - 02/2004
8Proteins (Proteins, Gene)FDA Link
12/2018 - 09/2005
7Panitumumab (Vectibix)FDA Link
12/2022 - 01/2017
7XELOXIBA
04/2022 - 05/2014
6Biomarkers (Surrogate Marker)IBA
04/2022 - 04/2015
6GemcitabineFDA Link
02/2019 - 11/2012
6Testosterone (Sustanon)FDA Link
01/2017 - 09/2009
5DNA (Deoxyribonucleic Acid)IBA
02/2022 - 02/2011
5human ERBB2 proteinIBA
11/2021 - 11/2014
5trifluridine tipiracil drug combinationIBA
07/2021 - 01/2020
5EnzymesIBA
11/2020 - 09/2005
5titanium silicide (TS-1)IBA
11/2016 - 08/2002
5Dizocilpine Maleate (Dizocilpine)IBA
02/2007 - 08/2004
4ThrombomodulinIBA
01/2022 - 06/2018
4Trastuzumab (Herceptin)FDA Link
11/2021 - 11/2015
4ErbB Receptors (EGF Receptor)IBA
07/2021 - 01/2012
4Warfarin (Coumadin)FDA LinkGeneric
06/2019 - 05/2007
4LipopolysaccharidesIBA
01/2019 - 01/2014
4TegafurIBA
01/2018 - 01/2014
4Cetuximab (Erbitux)FDA Link
11/2017 - 02/2011
4Progesterone Receptors (Progesterone Receptor)IBA
11/2014 - 11/2014
4Estrogen ReceptorsIBA
11/2014 - 11/2014
4NeuropeptidesIBA
11/2009 - 09/2005
4Memantine (Namenda)FDA Link
11/2009 - 08/2004
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2007 - 09/2004
3NivolumabIBA
01/2022 - 12/2019
3Sorafenib (BAY 43-9006)FDA Link
09/2021 - 11/2011
3Oxytocin (Pitocin)FDA LinkGeneric
01/2021 - 01/2015
3AnticoagulantsIBA
11/2020 - 06/2019
3Interleukin-6 (Interleukin 6)IBA
01/2019 - 09/2009

Therapy/Procedure

69Drug Therapy (Chemotherapy)
10/2022 - 11/2002
50Therapeutics
10/2022 - 01/2003
15Gastrectomy
02/2021 - 10/2004
13Lymph Node Excision (Lymph Node Dissection)
04/2022 - 09/2014
13Adjuvant Chemotherapy
07/2021 - 09/2014
12Hepatectomy
02/2022 - 11/2009
10Colectomy
11/2020 - 11/2007
9Neoadjuvant Therapy
12/2018 - 11/2012
7Radiotherapy
10/2020 - 11/2009
6Chemoradiotherapy
03/2022 - 05/2014
6Combination Drug Therapy (Combination Chemotherapy)
12/2018 - 11/2009
5Stents
11/2015 - 11/2011
4Proctectomy
03/2022 - 11/2016
4Pancreatectomy
02/2019 - 11/2015
4Pancreaticoduodenectomy
02/2019 - 11/2012
4Segmental Mastectomy (Lumpectomy)
11/2015 - 11/2008
3Catheter Ablation
02/2022 - 09/2020
3Laparotomy
11/2021 - 12/2016
3Ovariectomy (Oophorectomy)
01/2021 - 12/2014
3Palliative Care (Palliative Therapy)
03/2020 - 11/2009